These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 38223098)
21. The value of multiparametric MRI radiomics in predicting IDH genotype in glioma before surgery. Liang Y; Liu W; Bai D; Hu J; Wang Z Front Oncol; 2023; 13():1265672. PubMed ID: 38090497 [TBL] [Abstract][Full Text] [Related]
22. Multiparametric magnetic resonance imaging-based radiomics nomogram for predicting tumor grade in endometrial cancer. Yue X; He X; He S; Wu J; Fan W; Zhang H; Wang C Front Oncol; 2023; 13():1081134. PubMed ID: 36895487 [TBL] [Abstract][Full Text] [Related]
23. Using radiomics based on multicenter magnetic resonance images to predict isocitrate dehydrogenase mutation status of gliomas. Liu Y; Zheng Z; Wang Z; Qian X; Yao Z; Cheng C; Zhou Z; Gao F; Dai Y Quant Imaging Med Surg; 2023 Apr; 13(4):2143-2155. PubMed ID: 37064376 [TBL] [Abstract][Full Text] [Related]
24. Combining radiomics and deep convolutional neural network features from preoperative MRI for predicting clinically relevant genetic biomarkers in glioblastoma. Calabrese E; Rudie JD; Rauschecker AM; Villanueva-Meyer JE; Clarke JL; Solomon DA; Cha S Neurooncol Adv; 2022; 4(1):vdac060. PubMed ID: 35611269 [TBL] [Abstract][Full Text] [Related]
25. Predicting IDH subtype of grade 4 astrocytoma and glioblastoma from tumor radiomic patterns extracted from multiparametric magnetic resonance images using a machine learning approach. Kandalgaonkar P; Sahu A; Saju AC; Joshi A; Mahajan A; Thakur M; Sahay A; Epari S; Sinha S; Dasgupta A; Chatterjee A; Shetty P; Moiyadi A; Agarwal J; Gupta T; Goda JS Front Oncol; 2022; 12():879376. PubMed ID: 36276136 [TBL] [Abstract][Full Text] [Related]
26. Predicting N2 lymph node metastasis in presurgical stage I-II non-small cell lung cancer using multiview radiomics and deep learning method. Zhang H; Liao M; Guo Q; Chen J; Wang S; Liu S; Xiao F Med Phys; 2023 Apr; 50(4):2049-2060. PubMed ID: 36563341 [TBL] [Abstract][Full Text] [Related]
27. Prediction of the Molecular Subtype of IDH Mutation Combined with MGMT Promoter Methylation in Gliomas via Radiomics Based on Preoperative MRI. Sha Y; Yan Q; Tan Y; Wang X; Zhang H; Yang G Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900232 [TBL] [Abstract][Full Text] [Related]
28. Deep Learning Radiomics for the Assessment of Telomerase Reverse Transcriptase Promoter Mutation Status in Patients With Glioblastoma Using Multiparametric MRI. Zhang H; Zhang H; Zhang Y; Zhou B; Wu L; Lei Y; Huang B J Magn Reson Imaging; 2023 Nov; 58(5):1441-1451. PubMed ID: 36896953 [TBL] [Abstract][Full Text] [Related]
29. Multiregional radiomics profiling from multiparametric MRI: Identifying an imaging predictor of IDH1 mutation status in glioblastoma. Li ZC; Bai H; Sun Q; Zhao Y; Lv Y; Zhou J; Liang C; Chen Y; Liang D; Zheng H Cancer Med; 2018 Dec; 7(12):5999-6009. PubMed ID: 30426720 [TBL] [Abstract][Full Text] [Related]
30. Deep Learning-Assisted Quantitative Susceptibility Mapping as a Tool for Grading and Molecular Subtyping of Gliomas. Rui W; Zhang S; Shi H; Sheng Y; Zhu F; Yao Y; Chen X; Cheng H; Zhang Y; Aili A; Yao Z; Zhang XY; Ren Y Phenomics; 2023 Jun; 3(3):243-254. PubMed ID: 37325712 [TBL] [Abstract][Full Text] [Related]
31. Predicting Isocitrate Dehydrogenase (IDH) Mutation Status in Gliomas Using Multiparameter MRI Radiomics Features. Peng H; Huo J; Li B; Cui Y; Zhang H; Zhang L; Ma L J Magn Reson Imaging; 2021 May; 53(5):1399-1407. PubMed ID: 33179832 [TBL] [Abstract][Full Text] [Related]
32. Radiomics Strategy for Molecular Subtype Stratification of Lower-Grade Glioma: Detecting IDH and TP53 Mutations Based on Multimodal MRI. Zhang X; Tian Q; Wang L; Liu Y; Li B; Liang Z; Gao P; Zheng K; Zhao B; Lu H J Magn Reson Imaging; 2018 Oct; 48(4):916-926. PubMed ID: 29394005 [TBL] [Abstract][Full Text] [Related]
33. Coordinatized lesion location analysis empowering ROI-based radiomics diagnosis on brain gliomas. Liu X; Zhang Q; Li J; Xu Q; Zhuo Z; Li J; Zhou X; Lu M; Zhou Q; Pan H; Wu N; Zhou Q; Shi F; Lu G; Liu Y; Zhang Z Eur Radiol; 2023 Dec; 33(12):8776-8787. PubMed ID: 37382614 [TBL] [Abstract][Full Text] [Related]
34. Noninvasive Determination of Bhandari AP; Liong R; Koppen J; Murthy SV; Lasocki A AJNR Am J Neuroradiol; 2021 Jan; 42(1):94-101. PubMed ID: 33243896 [TBL] [Abstract][Full Text] [Related]
35. Preoperative Prediction of Perineural Invasion Status of Rectal Cancer Based on Radiomics Nomogram of Multiparametric Magnetic Resonance Imaging. Zhang Y; Peng J; Liu J; Ma Y; Shu Z Front Oncol; 2022; 12():828904. PubMed ID: 35480114 [TBL] [Abstract][Full Text] [Related]
36. Diffusion tensor imaging radiomics in lower-grade glioma: improving subtyping of isocitrate dehydrogenase mutation status. Park CJ; Choi YS; Park YW; Ahn SS; Kang SG; Chang JH; Kim SH; Lee SK Neuroradiology; 2020 Mar; 62(3):319-326. PubMed ID: 31820065 [TBL] [Abstract][Full Text] [Related]
37. Comparison of Radiomics Analyses Based on Different Magnetic Resonance Imaging Sequences in Grading and Molecular Genomic Typing of Glioma. Huang WY; Wen LH; Wu G; Hu MZ; Zhang CC; Chen F; Zhao JN J Comput Assist Tomogr; 2021 Jan-Feb 01; 45(1):110-120. PubMed ID: 33475317 [TBL] [Abstract][Full Text] [Related]
38. Radiomics features based on MRI predict BRAF V600E mutation in pediatric low-grade gliomas: A non-invasive method for molecular diagnosis. Xu J; Lai M; Li S; Ye K; Li L; Hu Q; Ai R; Zhou J; Li J; Zhen J; Cai L; Shi C Clin Neurol Neurosurg; 2022 Nov; 222():107478. PubMed ID: 36244075 [TBL] [Abstract][Full Text] [Related]
39. Reproducible imaging-based prediction of molecular subtype and risk stratification of gliomas across different experience levels using a structured reporting system. Nam YK; Park JE; Park SY; Lee M; Kim M; Nam SJ; Kim HS Eur Radiol; 2021 Oct; 31(10):7374-7385. PubMed ID: 34374800 [TBL] [Abstract][Full Text] [Related]
40. Integrated CT Radiomics Features Could Enhance the Efficacy of Zhou W; Huang Q; Wen J; Li M; Zhu Y; Liu Y; Dai Y; Guan Y; Zhou Z; Hua T Front Oncol; 2021; 11():772703. PubMed ID: 34869011 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]